Novartis Lp(a) drug fails to lower cardiovascular risk in closely watched ph. 3 trial Read more

Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline Read more

Menarini signs $771M deal to take Gan & Lee GLP-1 to European market Read more

Navid Gholampour

Navid has over a decade of experience in Life Sciences recruitment. He partners with leaders to build patient-focused and innovative organisation